Journal · Updated 2026-08-11
What the First 90 Days on a GLP-1 Actually Cost, Channel by Channel
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
Ninety-day budgets, by lane, tirzepatide then semaglutide. Brand tirzepatide (LillyDirect vials, titrating on label): month one at $299 (2.5 mg), months two-three at $399 (5 mg) — ~$1,097, well under the $1,347 steady-state quarter, because titration rides the cheaper rungs. Compounded tirzepatide (flat tier): $507–$537 ($169–$179 × 3), identical at every dose by design. Brand semaglutide pens: the $199 introduction covers two starter fills, month three at $349 — ~$747, the cheapest brand quarter either molecule offers. Oral Wegovy: ~$447 at the $149 tier. Compounded semaglutide: $387–$417 monthly-flexible, or the committed plans' quarter-share. Insured anything: $75–$150 in copays. The pattern: brand channels are engineered to make quarter one gentle; the divergence arrives in month four.
Month four, and the one-time costs
The startup discounts expire on schedule: brand tirzepatide steps onto the $449 rung as titration passes 7.5 mg (the steady-state quarter becomes $1,347); the pen introduction ends and $349 becomes the number; oral's $149 tier carries its August 31 date; and promotional compounded rates (NexLife's $169) either locked at signup or didn't — the enrollment confirmation decided which, back in week one, which is why the teaser index keeps insisting the ongoing rate get captured in writing before the first charge. One-time costs cluster early and belong in the quarter's budget honestly: syringes and sharps disposal for compounded vials (modest), any intake or membership fees (all-in programs have none — a filter this site applies for you), and the optional-but-recommended baseline labs some prescribers order. What doesn't belong: "program fees" discovered at checkout, dose-escalation surcharges, or month-four repricing you didn't sign — each a documented pattern, each a reason the first-90-days paper trail (enrollment confirmation, label photos, receipts) is the cheapest insurance in this market.
Questions people ask
How much does it cost to start tirzepatide?
First 90 days: ~$1,097 at LillyDirect (titration rides the $299/$399 rungs before the $449 maintenance tier), $507–$537 at flat compounded programs, or $75–$150 insured. The brand's gentle first quarter steps up in month four as doses climb — budget steady state, not startup.
How much does it cost to start semaglutide?
First 90 days: ~$747 for brand pens (two $199 intro fills + one $349), ~$447 for oral Wegovy at the $149 tier, $387–$417 compounded monthly, or copays insured. The intro pricing makes brand semaglutide's first quarter the cheapest in either molecule — then $349 becomes the number.
What surprise costs show up after starting a GLP-1?
The scheduled ones: brand dose-rung increases, intro-price expirations, promo rates that weren't locked in writing. The illegitimate ones: checkout-discovered program fees, dose-escalation surcharges, month-four repricing — all documented patterns, all preventable by capturing the ongoing rate in your enrollment confirmation before paying.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.